Objectives: Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. However, the concentrations of each of the oligosaccharide of human colostrum have not yet been determined. The aim of this present study was to determine the concentration of each of the major neutral oligosaccharide for three consecutive days from the start of lactation. Method: We analyzed the level of each neutral oligosaccharide in human colostrum, for three consecutive days from the start of lactation, obtained from 12 healthy Japanese women (ranging in age from 21 to 35 years; primipara 6 and multipara 6). The ABO blood groups of the donors were determined: A, three; B, three; O, five; AB, one. The determined human milk oligosaccharides were 2 0 -fucosyllactose (2 0 -FL), 3-fucosyllactose (3-FL), lactodifucotetraose (LDFT), lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), three lacto-N-fucopentaose (LNFP I, II and III) and two lacto-N-difucohexaose (LNFDH I and II) using high-performance liquid chromatography (HPLC) with two derivatization techniques. Results: The concentrations of 2 0 -FL and LDFT in colostrum on day 1 were significantly higher than those on days 2 and 3 (Po0.05). An increase in LNT was observed on day 3 compared with day 1 (Po0.05). Conclusion: These changes in concentrations of 2'-FL, LDFT and LNT may reflect the requirements for prebiotics and antiinfection agents by human infants during early lactation.
Introduction
Human milk oligosaccharides generally represent a large proportion of the total solids with components. Human colostrum and mature milk contain 22-24 g/l and 12-13 g/l of oligosaccharides, respectively; this oligosaccharide fraction is the third largest solid components, after lactose and lipid (Newburg and Neubauer, 1995) . The oligosaccharide content of human milk is about 20-fold higher than that of bovine milk and is even higher than that of bovine colostrum (Veh et al., 1981; Nakamura et al., 1998) . Human milk is also considered to be unique in its high content of complex fucosylated and sialylated oligosaccharides (Kunz et al., 1999) . The structures of at least 93 neutral and acidic oligosaccharides have been identified (Kobata et al., 1978) , but the presence of approximately 130 is suggested from mass spectrometry data (Newburg and Neubauer, 1995) . There is now accumulating evidence, described in several recent reviews (Newburg, 1996; Kunz et al., 2000) , that human milk oligosaccharides can function to protect the infant against pathogenic organisms. It is believed that human milk oligosaccharides are undigested and arrive unmodified at the intestinal tract (Gnoth et al., 2000) . The oligosaccharides act as soluble receptor analogues, inhibiting the attachment of pathogenic microorganisms or bacterial toxins to the infant gastrointestinal tract, and as prebiotics, stimulating the growth of colonic Bifidobacteria (Dai et al., 2000; Coppa et al., 2004) . The neutral oligosaccharides, especially, have been suggested to play an important role in prophylaxis against many pathogens (Newburg, 1997) . For example, fucosyloligosaccharides have been shown to inhibit the diarrhea caused by the action of the heat stable toxins of Escherichia coli, Campylobacter jejuni, Calicivirus, Salmonella fyris and Vibrio cholerae (Newburg et al., 1990; Morrow et al., 2004; Coppa et al., 2006) .
Although a large number of studies have been performed on the functions as well as the structures of specific human oligosaccharides, only a few publications have described changes in their contents during the course of lactation (Chaturvedi et al., 1997 (Chaturvedi et al., , 2001 Coppa et al., 1999; Sumiyoshi et al., 2003a, b; Musumeci et al., 2006) .
It is well recognized that milk is important for the health of mammalian neonates, especially during early lactation. Changes in the contents of several components in milk may be relevant to the mechanisms by which newborn babies are protected against infection by pathogenic microorganisms. In view of the above-mentioned properties of the neutral oligosaccharides, it would seem that their concentrations should be determined, especially during early lactation; such data may help to clarify the significance of each oligosaccharide in relation to the health of human infants. To this end, we have attempted to determine their concentrations in colostrum collected on three consecutive days starting from day 1 (2 days after delivery) to day 3 (4 days after delivery) of lactation, in the same donors.
Materials and methods

Samples
Milk samples from 12 healthy Japanese women (ranging in age from 21 to 35 years; primipara 6 and multipara 6). All their babies had been delivered vaginally and at full term. Milk samples were collected at the start of lactation (day 1), that is, 2 days post-partum, as well as on the following two days (days 2 and 3). All samples (approximately 3 ml each) were obtained from Keiai Hospital in Obihiro City during suckling (from 06:00 to 18:00) and stored in sterile tubes at À801C until analysis. The ABO blood groups of the donors were determined: A, three; B, three; O, five; AB, one. We obtained informed consent from all the donors to use their milk, using the protocol approved by Obihiro University of Agriculture and Veterinary Medicine.
Chemicals 1-Methyl-3-phenyl-5-pyrazolone (PMP) and 2-aminopyridine (PA) reagents were purchased from Wako Chemicals (Tokyo, Japan). All other chemicals were of the highest grade commercially available. 2 0 -Fucosyllactose (2 0 -FL), 3-fucosyllactose (3-FL) and lacto-N-fucopentaose I (LNFP I) were purchased from SIGMA Co (St Louis, MO), whereas lactodifucosyllactose (LDFT), lacto-N-tetraose (LNT), lacto-Nneotetraose (LNnT), lacto-N-fucopentaose II (LNFP II), lacto-N-fucopentaose III (LNFP III), lacto-N-difucohexaose I (LNDFH I) and lacto-N-difucohexaose II (LNDFH II), were from Dextra Laboratory (Reading, UK). Isomaltotriose and isomaltopentaose were obtained from Seikagaku Co (Tokyo, Japan).
Isolation of the neutral oligosaccharides fraction from human milk The milk samples were thawed and 1.0 ml of each, together with 40 ml of internal standard solution (containing 2 mg of each of isomaltotriose and isomaltopentaose), was extracted with four volumes of chloroform/methanol (2:1, v/v). The emulsion was centrifuged at 3500 r.p.m. for 15 min at 41C and the lower chloroform layer and denatured protein were discarded. The upper layer was collected and evaporated to about 200 ml. The resulting solution was called the 'carbohydrate fraction'.
The carbohydrate fraction was dissolved in 2 ml of water and the solution was passed through a Bio Gel P-2 (Extra fine, o45 mm; Bio Rad Laboratories, Hercules, CA, USA) column (2.6 Â 100 cm), which had been calibrated with 2 mg of isomaltotriose (trisaccharide) and isomaltopentaose (pentasaccharide). Elution was performed with water at a flow rate of 15 ml/h, and the elution profile was recorded with a Refractive Index apparatus (RI-8020; TOSOH Co, Tokyo, Japan), connected to a Smart Chrom program package (version 2.12J for windows computer system, KYA Technologies Co, Tokyo. Japan). Each fraction was 5 ml. Each peak (shown as Pools 1 and 2 in figures and tables) was pooled and freeze-dried.
Derivatization of the neutral oligosaccharides PMP derivatization of the neutral oligosaccharides fraction was performed according to the method of Honda et al. (1989) . Two hundred microliters of 0.5 M PMP in methanol and 100 ml of 0.6 M NaOH were added to each of both Pools 1 and 2 (half of each), which had been separated by gel chromatography on Bio Gel P-2 (see Figure 1 ). The reaction mixture was incubated on a heat block at 701C for 30 min. After cooling to room temperature, 600 ml of 0.1 M HCl and 1 ml chloroform were added and the solution was mixed for 30 s using a Vortex mixer. The upper aqueous layer was carefully transferred to a test tube using a Pasteur pipette. This extraction step with chloroform was repeated three times. The supernatant was evaporated, freeze-dried, and stored at À801C until HPLC (high-performance liquid chromatography) analysis. Twelve standard saccharides (each 50, 100, 200 and 400 mg) were derivatized by the same procedure to obtain a standard curve and recovery data for each.
The PA derivative of each neutral oligosaccharide fraction was prepared according to the method, which was a modification of the method originally described by Takemoto et al. (1985) . Coupling reagent (100 ml) (552 mg of 2-aminopyridine in 0.2 ml acetic acid) was added to half of each Pool 2 sample contained in a screw-cap tube. The tube was sealed with a screw-cap and heated at 901C for 1 h, after which 100 ml of freshly prepared reducing reagent (195 mg borane-dimethylamine complex in 1 ml acetic acid) was added. The tube was re-sealed and heated at 801C for 50 min. The resulting PA derivatives were separated from the reaction mixture by electrodialysis using a Microacilyzer model G-1 (Asahi Kasei Co., Kanagawa, Japan) within a 120-10 cartridge, followed by freeze-drying.
Most derivatized standard samples were checked by proton magnetic resonance ( 1 H-NMR) spectra, which were compared with the spectrum of each peak fraction sample separated by HPLC. 1 H-NMR spectra were recorded in D 2 O (100.00 atom D%, Aldrich, Milwaukee, USA) at 500 MHz with a JEOL ECP-500 FT-NMR spectrometer operated at room temperature with acetone as an internal standard at d 2.225.
HPLC analysis of PMP and PA-labeled neutral oligosaccharides
The PMP-or PA-labeled neutral oligosaccharides fraction was dissolved in 500 ml of water, followed by filtration through a DISMIC-13CP membrane (0.45 mm, cellulose acetate membrane; Advantec Toyo, Tokyo, Japan). Ten microliters of the solutions were subjected to reverse-phase HPLC using an Inertsil ODS-3V column (4.6 Â 250 mm, packed with 5 mm particles having 100 Å pore size; GL Sciences Inc, Tokyo, Japan) and an ODS-100Z column (4.6 Â 250 mm, packed with 5 mm particles having 100 Å pore size; TOSOH, Tokyo, Japan) for the analysis of Pool 1 and Pool 2, respectively, at 401C in a column oven L-7200 (Hitachi Co., Tokyo, Japan). The elution was controlled using a pump L-7100 (Hitachi) equipped with a system controller D-7000 (Hitachi). The PMP-labeled components in Pool 1 were eluted with 100 mM potassium phosphate buffer (pH 7.0), containing 16% acetonitrile at a flow rate of 1 ml/min for 60 min (chromatogram in Figure 2 ). The PMP-labeled components in Pool 2 were eluted with 100 mM ammonium acetate buffer (pH 4.5), containing 10 and 25% acetonitrile, denoted as buffer A and B, respectively, using a linear gradient of 84-64% of buffer B for 70 min at a flow rate of 0.4 ml/min (chromatogram in Figure 3 ). Detection was performed with a UV-detector L-7450 (Hitachi) by monitoring the absorption of the eluates at 245 nm. Peak areas were calculated using the chromatography data system D7000 analysis software.
Pyridylaminated neutral oligosaccharides in Pool 2 samples were analyzed by the same reverse-phase HPLC system as that used for the PMP-labeled oligosaccharides. 200 mM citric acid buffer (pH 5.0) was used as an isocratic mobile phase (chromatogram in Figure 4) . Elution was at a flow rate Figure 1 Gel chromatograms of the carbohydrate fraction from human milk on each day of lactation using internal standards. A Bio-Gel P-2 column (2.6 Â 100 cm) was used. Elution was performed with distilled water at a flow rate of 15 ml/h and fractions of 5.0 ml were collected. Each fraction was monitored by Refractive Index with Smart Chrom software. HPLC was performed on a column of ODS-3V (4.6 Â 250 mm, pore size 100 Å , particle size 5 mm) as described in Materials and methods.
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S Asakuma et al of 1 ml/min for 60 min, and the eluate was monitored by measuring its absorption at 310 nm. The recovery for each sample was calculated from that of the internal standard, which was more than 98%. The concentration of each oligosaccharide was calculated using the following formula:
f ðxÞ ¼ area data in chromatogramÂstandard curve factorÂCF: f ðxÞ : the concentration of each neutral oligosaccharide in sample: CF : correction factor ðsample 0 s internal standard area= 2mg internal standard areaÞ:
Statistical analysis
All values were represented by the mean7s.d. Statistical analysis was performed using JMP 5.1 software (SAS Institute Inc Cary, NC). All data were analyzed by the linear mixed model with donors as random and the day of lactation as fixed. To determine the statistical significance of the difference in the level of each oligosaccharide during the experimental period (from days 1 to 3), we used the TukeyKramer comparison test. P values of less than 0.05 were considered significant.
Results
The gel chromatograms on Bio-Gel P-2 of the carbohydrate fractions from colostrum collected on days 1 to 3 of lactation are shown in Figure 1 . The fractions constituting Pools 1 and 2 contained only neutral oligosaccharides. The neutral oligosaccharides quantified in the present study are listed in Table 1 . It was shown by HPLC that these two peaks contained the following oligosaccharides ; 2 0 -FL, 3-FL, LDFT and isomaltotriose in Pool 1 and LNT, LNnT, LNFP I, LNFP II, LNFP III, LNDFH I, LNDFH II and isomaltopentaose in Pool 2. Figures 2-4 show representative chromatograms of HPLC of the PMP-derivatized neutral oligosaccharides in Pools 1 and 2, and those of PA derivatives in Pool 2.
As it was found that the peak of the PMP derivative of LNT overlapped with that of LNnT, the levels of LNT and LNnT were obtained by determination of their PA derivatives. The PMP or PA derivatives of LNFP II and LNFP III could not be separated from each other by HPLC; their content was therefore shown as LNFP II þ LNFP III, as calculated from the LNFP II standard curve. Table 2 shows the mean concentration of each of nine neutral oligosaccharides from days 1 to 3 of lactation. The combined average values for the neutral major oligosaccharides in human colostrum were 2.0371.67 mg/ml for 2 0 -FL, 1.7470.21 mg/ml for LNDFH I, 1.5171.02 mg/ml for LNFP I, and 1.2670.67 mg/ml for LNT. Pool 2 collected after gel filtration from human colostrum from each donor. HPLC was performed on a column of ODS-100Z (4.6 Â 250 mm, pore size 100 Å , particle size 5 mm) as described in Materials and methods.
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The highest concentrations of both 2 0 -FL and LDFT were found on day 1 of lactation. The levels of these oligosaccharides significantly decreased from days 1 to 3 (Po0.05). By contrast, the concentration of LNT on days 2 and 3 was significantly higher than that on day 1 (Po0.05). The concentration of LNnT was higher on day 2 than on days 1 and 3, and we observed the same tendency for LNFP I and LNDFH I. The concentrations of LNFP II þ III and LNDFH II did not significantly change during these 3 days.
Discussion
This is the first study that has documented changes in each of the major neutral oligosaccharides of human colostrum, from the beginning of lactation to the third day (from 2 to 4 days after delivery). It is generally considered that the early stage milk/colostrum is more significant for the protection of neonates than that secreted during mid-and late stages (Ogra and Ogra, 1988) .
In this study, it was shown that the concentrations of 2 0 -FL, LNFPI, LNDFHI and LNT were higher than those of the other five saccharides. These results are similar to previous data obtained by other HPLC techniques at other lactation periods (Thurl et al., 1996; Chaturvedi et al., 1997; Coppa et al., 1999; Morrow et al., 2005) . Musumeci et al. (2006) reported the levels of 2 0 -FL and LNFP I in the colostrum of Italian and Burkinabe women collected the first three days from the start of lactation. In contrast to our results, their data showed a progressive appearance of these oligosaccharides during this time. Furthermore, in their study, the concentrations of 2 0 -FL and LNFP I on day 3 were higher than ours. This difference may be partly due to the different ethnic origins of the donors and to different time of colostrum collection.
As the result of present study, the concentrations of the two a1-2 fucosylated saccharides (2 0 -FL and LDFT) were obviously higher on day 1 than on days 2 and 3, in contrast to 3-FL whose concentration remained more or less constant. This suggests that a1-2 fucosylated oligosaccharides might be important for infants immediately after birth. It has been reported that a2-linked fucosylated oligosaccharides of human milk control diarrhea caused by the heat-stable toxin of E. coli (Cleary et al., 1983; Newburg et al., 1990) and that Intestinal infection by C. jejuni is one of the most common causes of diarrhea world wide and is the primary cause of ascending motor neuron paralysis.
It is generally considered that the biosynthesis of milk oligosaccharides from lactose is regulated by the expression of glycosyltransferases. The transfer of fucose from GDPfucose to a non-reducing galactose of the acceptor oligosaccharides (Grollman et al., 1965) , via an a1-2 fucosyl linkage, is catalyzed by an a1-2 fucosyl transferase that is mainly produced by the secretor gene (Oriol et al., 1999) . The concentration of each of the neutral oligosaccharide in human milk or colostrum is known to be related to the expression of specific mammary gland glycosyltransferases, whose activities are genetically determined. There is a strong relationship between the milk oligosaccharide phenotype and the Lewis blood group phenotype, which implies a common genetic control (Thurl et al., 1997) . Although little is known about changes in the activities of fucosyltransferases of the human mammary gland during lactation, our data suggest that the activity of a1-2 fucosyltransferase gradually decreases during the first 3 days of lactation.
Our results also showed that the level of LNT increased from days 1 to 3 of lactation. An intestinal flora with a predominance of bifidobacteria is usually formed in the colon of breastfed infants within 1 week after birth (Rotimi and Duerden, 1981; Yoshioka et al., 1983; Benno et al., 1986) . Ward et al. (2006) also indicated in vitro that some of human milk oligosaccharides were fermented by Bifidobacterium infantis. There has long been doubt concerning the exact nature of the milk oligosaccharides that are responsible for stimulating the growth of bifidobacteria. Kitaoka et al. (2005) recently suggested that sugars containing a lacto-N-biose unit (Gal(b1-3)GlcNAc), such as LNT, are implicated. Our data suggest that the increase of LNT content in the milk during days 1 to 3 may be related to the postnatal formation of bifidus flora in the infant colon. In addition, one should consider the physiological role of LNFP I and LNDFH I, because these oligosaccharides contain both an a1-2 fucosyl residue and the lacto-N-biose structure. It is possible that LNFP I may also be a bifidobacterium growth-stimulating factor, since Katayama et al. (2004) found a gene for a2 fucosidase in a genomic library of Bifidobacterium bifidum constructed in E. coli. This enzyme hydrolyses LNFP I to LNT and fucose. However, further studies are required to clarify the functions of these neutral oligosaccharides, both in vivo and in vitro.
In conclusion, the decrease of 2 0 -FL and increase of LNT concentrations during days 1 to 3 may be related to significant changes in anti-infection properties of human colostrum, although it is possible to conclude that the protective role could be the result of the simultaneous and joint action of several oligosaccharides interacting with both one single species of microorganism and with more than one. Soluble receptor analogues may be important for infants immediately after birth, after which prebiotic mechanisms may become more important.
